Loading
AP
Anacor Pharmaceuticals, Inc. Stock: price and insider trades · United States
Anacor Pharmaceuticals, Inc.: what insiders have been doing
Every trade that managers of Anacor Pharmaceuticals, Inc. disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for Anacor Pharmaceuticals, Inc. The previous disclosure was published on 5 February 2016.
For comparison within the same market, see the insider buying recorded at Relmada Therapeutics, Inc. and Uber Technologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
21
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
14 ops. · all time
Last declaration on 5 February 2016
Declarations21 total
6,250 sharesCommon StockSEC:0001209191-16-096107:0
5,000 sharesCommon StockSEC:0001209191-16-096109:0
5,000 sharesCommon StockSEC:0001209191-16-096102:0
14,584 sharesCommon StockSEC:0001209191-16-096104:0
20,000 sharesCommon StockSEC:0001209191-16-092996:0
1,200 sharesCommon StockSEC:0001209191-16-092996:1
13,300 sharesCommon StockSEC:0001209191-16-092996:2
5,300 sharesCommon StockSEC:0001209191-16-092996:3
200 sharesCommon StockSEC:0001209191-16-092996:4
80 sharesCommon StockSEC:0001209191-16-089483:0
333 sharesCommon StockSEC:0001209191-16-089485:1
200 sharesCommon StockSEC:0001209191-16-089485:2
100 sharesCommon StockSEC:0001209191-16-089486:0
555 sharesCommon StockSEC:0001209191-16-089486:1
200 sharesCommon StockSEC:0001209191-16-089486:2
233 sharesCommon StockSEC:0001209191-16-089483:2
200 sharesCommon StockSEC:0001209191-16-089485:0
2,220 sharesCommon StockSEC:0001209191-16-089483:1
21 of 21 declarations
About Anacor Pharmaceuticals, Inc.
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for dermatological diseases. It is listed on NASDAQ under the ticker ANAC.
